BDSX - Company ID 0001439725
The table below shows BIODESIX INC's cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$10.17M | -$8.60M | -$15.31M | -$7.69M | -$13.10M | -$11.33M |
| Capital expenditure | $81.00K | $74.00K | $234.00K | $7.68M | $262.00K | $466.00K |
| Investing cash flow | -$144.00K | -$137.00K | -$273.00K | -$7.71M | -$352.00K | -$516.00K |
| Dividends paid | - | - |
BIODESIX INC reported operating cash flow of -$23.27M for fiscal year 2025. That is up 52.2% from -$48.65M in fiscal 2024. Over the 7 fiscal years shown, operating cash flow declined from -$21.73M (FY 2019) to -$23.27M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| - |
| - |
| - |
| Stock buybacks | - | - | - | - | - | - |
| Financing cash flow | $16.90M | $97.00K | $791.00K | -$2.42M | -$2.83M | $4.95M |